Marchex (MCHX) EBIT (2010 - 2026)

Marchex (MCHX) has reported EBIT for 17 consecutive years, with -$346000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBIT rose 35.45% year-over-year to -$346000.0 in Q2 2026; TTM through Jun 2026 was -$4.2 million, a 12.82% increase from a year earlier, with the FY2025 full-year figure at -$5.7 million, down 28.72% from the prior year.
• EBIT was -$346000.0 for Q2 2026 at Marchex, up from -$2.4 million in the prior quarter.
• Over five years, EBIT peaked at -$346000.0 in Q2 2026 and troughed at -$4.5 million in Q1 2023.
• A 5-year average of -$1.7 million and a median of -$1.5 million in 2022 frame the typical range for EBIT.
• Across the five-year window, EBIT plunged 194.12% in 2023 and surged 73.25% in 2024, its largest moves.
• Over 5 years, EBIT stood at -$3.5 million in 2022, then soared by 68.17% to -$1.1 million in 2023, then tumbled by 41.57% to -$1.6 million in 2024, then plunged by 49.84% to -$2.4 million in 2025, then jumped by 85.45% to -$346000.0 in 2026.
• The last three EBIT figures came in at -$346000.0 (Q2 2026), -$2.4 million (Q4 2025), and -$941000.0 (Q3 2025), per Business Quant data.